Live Breaking News & Updates on Genomic Medicines

Stay updated with breaking news from Genomic medicines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pakistan and Swiss scientists' cooperation stressed for collective good of people

Islamabad: The participants of Pak-Swiss workshop on Genomic Medicines and Earthquake Engineering stressed the need of enhancing and collaboration between the Pakistan and Swiss scientists for the. ....

Shahid Mahmood Baig , Alberto Groff , Switzerland Embassy Alberto Groff , Deputy Head Of Mission , Pakistan Science Foundation Prof , Pakistan Science Foundation , Genomic Medicines , Earthquake Engineering , Swiss Universities , Deputy Head , Chairman Pakistan Science Foundation ,

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

/PRNewswire/ Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that. ....

United States , Christopher Riley , Rainer Blair , Boston Consulting Group , Master Of Business Administration , Group Executive Of Danaher Life Sciences , University Of Illinois , Group Executive For Danaher Diagnostics , Danaher Corporation , Pall Corporation At Danaher , Kellogg At Northwestern University , Executive Vice President , Vice President , Group Executive , Life Sciences , Genomic Medicines , Chief Executive Officer , Danaher Business System , High Growth Markets , Pall Corporation , Boston Consulting , Mechanical Engineering , Business Administration , Quarterly Report ,

REGENXBIO Announces Presentation at the Barclays Gene Editing & Therapy Summit 2023

ROCKVILLE, Md., May 22, 2023 /PRNewswire/ REGENXBIO Inc. today announced that it will present in a fireside chat and panel as well as host one-on-one investor meetings at the Barclays Gene. | May 22, 2023 ....

Chris Brinzey , Dana Cormack , Technology Platform , Corporate Communications , Technology Platform Licensees , Barclays Gene Editing , Therapy Summit , Gene Editing , Genomic Medicines , Are We Ready , Platform Licensees , Regenxbio Inc Stock Exchange , Press Release , Arclays Rgnx Us75901b1070 ,

Turn Biotechnologies to Present at the Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days

/PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced. ....

Jim Martinez , Anja Krammer , Turn Biotechnologies , Chief Executive Officer , Guggenheim Healthcare Talks , Genomic Medicines , Rare Disease Days , Epigenetic Reprogramming , Delivery Platform ,

Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days

LEIDEN, The Netherlands, March 30, 2023 /PRNewswire/ Pharming Group N.V. announces that Pharming s Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor, will. | March 30, 2023 ....

Noord Holland , New York , United States , Stephen Toor , Pharming Group , Euronext Amsterdam , Chief Executive Officer , Sijmen De Vries , Chief Commercial Officer , Guggenheim Healthcare Talks , Genomic Medicines , Rare Disease Days , Investor Relations , North America , Middle East , Pharming Groupnv Stock Exchange , Press Release , Tephen Phar Us71716e1055 ,